This website provides information about laboratory diagnostic services. The analyses presented are not therapeutic and do not replace medical diagnosis and treatment. Medical decisions are made exclusively by your treating physician.
Revolutionary breast cancer tumor diagnostics with state-of-the-art Liquid Biopsy technology! Our innovative breast cancer cancer diagnostics or breast cancer blood test enables precise diagnoses to be made by simply taking a blood sample without the need for stressful tissue sampling.
The Liquid Biopsy breast cancer method analyzes circulating tumor cells and tumor DNA in the blood for a gentle breast cancer diagnosis. Our breast cancer blood test offers you a minimally invasive alternative to conventional tissue sampling. The liquid breast cancer biopsy enables earlier detection and better follow-up.
With breast cancer diagnostics by ctc breast cancer analysis, we can obtain important information about your tumor. The breast cancer blood test and the circulating tumor cells breast cancer examination offer you state-of-the-art diagnostics for optimal treatment planning.
Advantages for breast cancer patients
through personalized diagnostics:
Optimal support at all stages of the disease
Breast cancer is the most common cancer in women worldwide. Despite standardized treatment protocols, tumors differ significantly in their molecular characteristics, which explains why patients respond differently to the same therapy. Personalized diagnostics using Liquid Biopsy marks a paradigm shift in the treatment of breast cancer and offers decisive advantages to affected patients at every stage of the disease.
Case study Beate S.
04.2020
Diagnosis Microinvasive multifocal breast carcinoma with extensive marginal DCIS
05.2020
Therapy: April 2020 subcutaneous mastectomy on the left. May 2020 secondary axillary LNE on the left
06.2020
1. iCOMPLETE test, taking the supplements and infusions
02.2021
2. iComplete test, after complementary therapy
11.2021
3. iComplete test, after complementary therapy
03.2022
4. iCOMPLETE Test
2022
Complete remission and return of cancer markers to the normal range
2024
2 years after complete remission still no signs of disease
Personalized diagnostics at all stages of breast cancer
iPREVENT
Application of the iPREVENT test: The early detection of molecular signatures in the blood means that diagnosis can be made at a stage where the chances of recovery can still be up to 100%. This is particularly relevant for patients with a family history or known genetic predispositions.
Stage 0
Early detection and prevention
Personalized diagnostics is revolutionizing the field of early detection, especially for high-risk patients:
- Highly sensitive detection of tumor markers: detection of circulating tumor cells in the blood long before imaging diagnostics
- Individual screening strategies: Adaptation of screening intervals to the personal risk profile
- Preventive benefits: If increased numbers of tumor cells are found in the blood, the iSelect or iComplete test can be used to investigate further and identify treatment options
Liquid Biopsy Breast Cancer – Gentle diagnostics without tissue removal
Liquid Biopsy breast cancer is revolutionizing breast cancer diagnostics through minimally invasive blood analysis. Our liquid biopsy breast cancer technology enables the detection of tumor cells in the blood without surgical intervention. Liquid Biopsy breast cancer gives you precise results with maximum patient comfort.
Breast cancer diagnostics – precise analysis for optimal therapy
Our breast cancer diagnostics use state-of-the-art molecular methods for precise tumour characterization. Breast cancer diagnostics includes genetic analyses to determine the optimal treatment strategy. Breast cancer diagnostics provides you with the basis for personalized treatment.
Breast cancer blood test – simple sample collection, precise results
The breast cancer blood test enables uncomplicated diagnostics by simply taking blood samples in the practice. Our breast cancer blood test analyzes various tumor markers and genetic changes. The breast cancer blood test saves you time and gives you fast, reliable diagnostic results.
CTC Breast Cancer – Circulating tumor cells as a diagnostic key
The ctc breast cancer analysis identifies and characterizes circulating tumor cells in the blood. Our circulating tumor cells breast cancer analysis provides important information about tumor aggressiveness and response to therapy. With ctc breast cancer diagnostics, we can optimally monitor treatment success and disease progression.
Stage I-II
Localized breast cancer
In the case of localized breast cancer without lymph node involvement, personalized diagnostics makes this possible:
- Gene expression analysis: Precise characterization of the tumor through analysis of approx. 35 gene expression markers - beyond the standard biomarkers
- Therapy support: Derivation of therapy options including complementary agents and so-called "repurposed drugs" based on the individual gene expression profile
- Repeated iSELECT tests enable therapy monitoring without the need for a new tumor biopsy, so that early molecular changes in the tumor can be detected and therapy decisions can be adjusted promptly
iSELECT
Application of the iSELECT test: In the case of localized breast cancer, molecular analysis can maximize the effectiveness of treatment and avoid unnecessary therapies. The test identifies the individual molecular weak points of the tumor and enables a tailored therapy with potentially good efficacy and minimal side effects.
iCOMPLETE
Application of the iCOMPLETE test: Comprehensive molecular characterization is crucial, especially in the stage with lymph node involvement. The test analyzes important parts of the tumor’s molecular profile and identifies active signaling pathways, resistance mechanisms and potential targets for targeted therapies.
Stage III
Breast cancer with lymph node involvement
In the case of tumors involving the lymph nodes, personalized diagnostics offers:
- Identification of treatment options: Mention of therapeutic agents that may be effective for the tumor in question
- Resistance factors: Identification of mechanisms that could limit the response to standard therapies
- Monitoring therapy response: early detection of therapy failure through analysis of circulating tumor cells
Stage IV
Metastatic breast cancer
In advanced disease with distant metastases, personalized diagnostics is of particular importance:
- Presentation of possible treatment options: Identification of therapeutic agents that may not be effective for the tumor in question
- Therapy monitoring: Identification of the transformation of the tumor during therapy
- Response monitoring: monitoring the success of therapy without repeated invasive biopsies
- Identification of target structures: development of treatment options beyond standard therapies
iCOMPLETE
Application of the iCOMPLETE test: In metastatic breast cancer, continuous molecular monitoring is important in order to detect resistance to therapy at an early stage and adapt treatment strategies. The test enables longitudinal monitoring of the molecular tumour profile and supports the development of individualized therapy concepts for each phase of the disease.
iPREVENT
Application of the iPREVENT test: In the follow-up phase, the test enables highly sensitive monitoring for recurrences and thus offers the opportunity to intervene much earlier if the disease recurs. This can significantly improve the prognosis for recurrences.
afterwards
Aftercare and monitoring after therapy
Once primary therapy has been completed, personalized diagnostics offers significant advantages:
- Detection of minimal residual disease (MRD): Detection of remaining tumor cells below the imaging detection limit
- Early relapse detection: Molecular signatures of relapse months before clinical manifestation
- Personalized follow-up intervals: adaptation of check-ups to the individual risk profile
- Monitoring of long-term therapies: Monitoring of efficacy and development of resistance during therapy
Special molecular properties of breast cancer
Personalized diagnostics takes into account the specific molecular characteristics of breast cancer:
1. molecular subtypes and their clinical relevance
- Luminal A: Slow-growing, hormone receptor-positive tumors with excellent prognosis
- Luminal B: More aggressive hormone receptor-positive tumors, often with additional molecular alterations
- HER2-positive: Characterized by HER2 overexpression/amplification, response to anti-HER2 therapies
- Triple-negative: Heterogeneous group with different molecular subtypes, including:
- Basal subtypes
- Immunogenic subtypes
- Androgen receptor-positive subtypes
- Mesenchymal subtypes
2. frequent molecular alterations and therapy implications
- PIK3CA mutations: Common in hormone receptor-positive tumors, response to PI3K inhibitors
- ESR1 mutations: Development under endocrine therapy, resistance to certain hormone therapies
- BRCA1/2 mutations: Defects in DNA repair, response to PARP inhibitors
- CDK4/6 activation: cell cycle dysregulation, response to CDK4/6 inhibitors
- PD-L1 expression: immune evasion, predictor of immunotherapy response
Personalized diagnostics
Foundation for a new era of breast cancer treatment
Personalized diagnostics using Liquid Biopsy marks the transition from standardized treatment protocols to truly individualized therapy concepts. Seamless integration into the entire treatment pathway – from prevention and initial therapy to follow-up care and advanced disease – makes treatment decisions more precise, effective and gentle.
For breast cancer patients, this paradigm shift means individualized treatment at every stage of their disease, with the potential for better treatment outcomes, higher quality of life and ultimately improved chances of survival.
Our satisfied customers
We have helped many patients on their way
Awarded by our patients on Google
Jan Zimmermann
I was diagnosed with an oesophageal tumor in April 2024 and, thanks to the doctors’ quick response, I was able to
Find out more ⟶
start chemotherapy relatively early. In parallel I was undergoing complementary cancer treatment during which I also learned about iQMedix. Based on the information from a Metavectum Complete Test, I obtained and took the recommended natural remedies.
I have now beaten the cancer and what can I say, the chemo played its part, but I am sure that the complementary treatment and the natural remedies of the iQMedix test were decisive for my healing! Thank you very much, keep up the good work!
Ina Bergeest
After my cancer diagnosis, I learned about iQMedix and was inspired by a detailed conversation with Dr. Becker
Find out more ⟶
well informed. After a blood test (Metavectum Select), I received a detailed and comprehensive for me very helpful test report.
With the very good informative answers to all my questions, I am finding ways to track down the cancer cells with alternative medical solutions.
The test is definitely a very good and informative method for finding out information about processes in the body. I can only recommend it!
Thank you very much
Rainer Neumann
My doctor explained to me how iQMedix works and took blood for analysis. I find the approach of iQMedix
Find out more ⟶
exciting and, from my point of view (I’m just a patient), innovative.My doctor explained the very detailed results to me. That was 10 months ago, since then I have been following the suggestions and my condition has stabilized positively. In addition to the conventional medical approaches, the iQMedix approach is amazingly logical and has obviously been effective in my case so far.
Ingrid Müller-Raiser
Based on a blood sample from my husband, a Metavectum Compostela was created, so he could see which
Find out more ⟶
herbal substances – without side effects – and later chemotherapeutics really helped him. He beat his cancer in a very short time. A thousand thanks to the informed doctor.
Irma Kolic
Many thanks for the very competent and extremely friendly advice on the blood tests. Dr. Becker provided a detailed and
Find out more ⟶
very informative conversation with me and thanked me for it. start chemotherapy relatively early. In parallel I was undergoing complementary cancer treatment during which I also learned about iQMedix. Based on the information from a Metavectum Complete Test, I obtained and took the recommended natural remedies.
I have now beaten the cancer and what can I say, the chemo played its part, but I am sure that the complementary treatment and the natural remedies of the iQMedix test were decisive for my healing! Thank you very much, keep up the good work!
Dra. Janaiana Koenen
I am an endocrinologist in Brazil who specializes in the metabolic treatment of cancer.
Find out more ⟶
and I regularly recommend the iQMedix/Metavectum Cancer Blood Test with Gene Expression to my cancer patients as I find it extremely useful in customizing my prescription of supplements and repurposed medications. The test is very thorough and the company provides us with extensive support to understand not only the test but also its full applicability. I can’t wait to make this test available in Brazil for all oncology patients. The staff is very open to discussing the results and advising physicians who are learning about expression testing. So if you are a doctor, do not hesitate and contact them.
Marcus Lamm
Experienced and helpful staff. Advice was very good and the results in the report were also very good for me.
Find out more ⟶
helpful. I always received competent help with any questions I had. I would order a test there again at any time.
mdsport 999
Brilliant laboratory with very friendly and competent staff. We have a gene expression test here
Find out more ⟶
with very helpful results. We can recommend this laboratory without reservation!
Dr. Anthony Faro
As a doctor, I am always on the lookout for reliable laboratories that can help me manage the
Find out more ⟶
support my patients’ complaints. I was recently diagnosed with prostate cancer and began looking for ways to complement and enhance conventional treatments. I was impressed with these tests, so I traveled from the US to Germany to meet the company’s executives and perform the Metavectum Complete Panel on myself.
IQMedix has valuable genetic information
about my specific cancer and was helpful in the treatment of my tumor.
I can honestly say that this company is run by good people with good intentions. People who are motivated by the possibilities of helping people and not by money. I am grateful for their help and hospitality and will continue to support their efforts now and in the future. I look forward to offering Metavectum profiles in my office and introducing this technology to my colleagues in the US.
Bader
I have ordered the iQMedix/Metavectum cancer blood analysis with gene expressions, with the
Find out more ⟶
The aim is to find effective treatments with few side effects that can help replace high-risk treatments with severe side effects that could damage my health and reduce my quality of life or shorten my life if I use them too early.
I was delighted to discover,
that the test revealed several readily available supplements that can help me in this endeavor.
I am also reassured that the company does not sell drugs or products and therefore has no financial stake in its recommendations.
I am satisfied with the straightforward process of donating blood and having my doctor review the analysis.
I will update this review after I have used the newly recommended supplements for a while and collected my own data on their effectiveness.
Gemma Richardson
iQMedix is a very professional 5-star service. The test was well organized, with clear instructions and
Find out more ⟶
Test results provided within a timely time frame, regardless of whether our blood sample was sent from the UK. We would definitely recommend it to others.
Jp Lem
Find out more ⟶
offer a comprehensive overview of treatment options and their commitment to patient care is highly valued.
